Publications and Academic Initiatives

Make publications part of your trial strategy

Publications Office

The YCRG Publications Office is designed to facilitate the complete, ethical, and timely dissemination of clinical research results through high-impact peer-reviewed publications and podium presentations. The YCRG Publications Office facilitates structured collaboration between study investigators, committee members, and sponsors, while providing a scientifically independent resource to guide the creation and execution of a strategic publication plan.

JSCAI

Dr. Alexandra J. Lansky serves as editor in chief of JSCAI, the peer-reviewed, international, Gold Open Access official journal of the Society for Cardiovascular Angiography & Interventions. JSCAI covers all interventional cardiology subspecialities including coronary, peripheral, structural, and congenital heart disease. Dr. Lansky and Executive Editor Dominic Francese collaborate with the editorial board, SCAI staff, and Elsevier to publish high-impact science for the interventional cardiology community.

Academic Initiatives

The YCRG promotes academic initiatives to inform clinical practice guidelines and the design of future clinical trials. In collaboration with faculty members and industry partners, YCRG conducts systematic reviews and meta-analyses of published clinical trial data and individual participant data in various areas of cardiovascular medicine to assess the safety and performance of cardiovascular devices and neurologic risk associated with these interventions.

Recent Publications

2024

Long-Term Percutaneous Coronary Intervention Outcomes in Chronic Versus Acute Coronary Syndromes (TARGET All Comers Trial).Patel KP, Lansky AJ, Kelbæk H, Xu B, van Royen N, Johnson TW, Anderson R, Wijns W, Baumbach A. Am J Cardiol. 2024 Apr 15; 2024 Feb 11. PMID: 38350507.
Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results from the TARGET BP I Randomized Clinical Trial.Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, Schmieder RE, Janas AJ, Langer C, Persu A, Mendelsohn FO, Ameloot K, Foster Iii M, Fischell TA, Parise H, Mahfoud F. Circulation. 2024 Apr 8; 2024 Apr 8. PMID: 38587557.
Long-term safety and effectiveness of the Fantom bioresorbable coronary artery scaffold: final results of the FANTOM II trial.Lutz M, Abizaid A, Nielsen Holck E, Lansky A, Carrié D, Weber-Albers J, Dudek D, Frey N, Christiansen EH, Holm NR, Stone GW. EuroIntervention. 2024 Apr 1; 2024 Apr 1. PMID: 38562069.
Addressing Barriers to Entry and Retention of Women in Interventional Vascular Specialties With Proposed Solutions: A Scientific Statement From the American Heart Association.Altin SE, Kwong M, Hamburg NM, Creager MA, Banerjee S, Oladini L, Schneider MD, Ruddy JM. Circulation. 2024 Mar 19; 2024 Feb 20. PMID: 38375663.
Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI.Abu-Much A, Grines CL, Batchelor WB, Maini AS, Zhang Y, Redfors B, Bellumkonda L, Bharadwaj AS, Moses JW, Truesdell AG, Li Y, Baron SJ, Lansky AJ, Basir MB, Cohen DJ, O'Neill WW. Am Heart J. 2024 Mar; 2023 Dec 26. PMID: 38151142.
Impact of sex on Transcatheter aortic valve replacement outcomes: Results of a single-center study.See C, Wang Y, Yang Y, Tirziu D, Papoutsidakis N, Francese DP, Kaple RK, Cleman M, Lansky AJ, Forrest JK. Int J Cardiol. 2024 Mar 1; 2023 Dec 6. PMID: 38065329.
Anatomic patterns in claudicants who fail supervised exercise therapy.Breen TJ, McGinigle K, Strosberg D, Dardik A, Altin SE. J Vasc Surg. 2024 Mar; 2023 Nov 19. PMID: 37984757.
Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Postapproval Study by Society of Cardiovascular Angiography and Interventions Shock Stage.Hanson ID, Rusia A, Palomo A, Tawney A, Pow T, Dixon SR, Meraj P, Sievers E, Johnson M, Wohns D, Ali O, Kapur NK, Grines C, Burkhoff D, Anderson M, Lansky A, Naidu SS, Basir MB, O'Neill W. J Am Heart Assoc. 2024 Feb 6; 2024 Jan 31. PMID: 38293995.
Sex-specific analysis of intravascular lithotripsy for peripheral artery disease from the Disrupt PAD III observational study.Nagpal S, Altin SE, McGinigle K, Mangalmurti SS, Adams G, Shammas NW, Mehrle A, Soukas P, Bertolet B, Lansky AJ. J Vasc Surg. 2024 Feb; 2023 Nov 2. PMID: 37925039.
The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually.Foley M, Rajkumar CA, Ahmed-Jushuf F, Nour D, Fung CH, Seligman H, Pathimagaraj RH, Petraco R, Sen S, Nijjer S, Howard JP, Ahmad Y, Allahwala U, Bhindi R, Chamie D, Doi S, Kuwata S, Kaihara T, Koga M, Ishibashi Y, Higuma T, Tanabe Y, Nakayama M, Kawase Y, Watanabe A, Funayama N, Horinaka R, Hijikata N, Takahashi T, Matsuo H, Hansen PS, Manica A, Weaver J, Alzuhairi K, Yong TH, Warisawa T, Francis DP, Shun-Shin MJ, Al-Lamee RK. Cardiovasc Revasc Med. 2024 Feb; 2023 Aug 12. PMID: 37612169.
Effect of antecedent statin usage on conduction disturbances and arrhythmias after transcatheter aortic valve replacement.Shah T, Maarek R, See C, Huang H, Wang Y, Parise H, Forrest JK, Lansky AJ. Cardiovasc Revasc Med. 2024 Feb; 2023 Jul 27. PMID: 37573173.
Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational Experimentation.Omerovic E, Petrie M, Redfors B, Fremes S, Murphy G, Marquis-Gravel G, Lansky A, Velazquez E, Perera D, Reid C, Smith J, van der Meer P, Lipsic E, Juni P, McMurray J, Bauersachs J, Køber L, Rouleau JL, Doenst T. Trials. 2024 Jan 23; 2024 Jan 23. PMID: 38263138.
Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Trials.Sreenivasan J, Reddy RK, Jamil Y, Malik A, Chamie D, Howard JP, Nanna MG, Mintz GS, Maehara A, Ali ZA, Moses JW, Chen SL, Chieffo A, Colombo A, Leon MB, Lansky AJ, Ahmad Y. J Am Heart Assoc. 2024 Jan 16; 2024 Jan 12. PMID: 38214263.
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review.Bikdeli B, Sadeghipour P, Lou J, Bejjani A, Khairani CD, Rashedi S, Lookstein R, Lansky A, Vedantham S, Sobieszczyk P, Mena-Hurtado C, Aghayev A, Henke P, Mehdipoor G, Tufano A, Chatterjee S, Middeldorp S, Wasan S, Bashir R, Lang IM, Shishehbor MH, Gerhard-Herman M, Giri J, Menard MT, Parikh SA, Mazzolai L, Moores L, Monreal M, Jimenez D, Goldhaber SZ, Krumholz HM, Piazza G. Semin Thromb Hemost. 2024 Jan 4; 2024 Jan 4. PMID: 38176425.
Approval, Evidence, and "Off-Label" Device Utilization: The Patent Foramen Ovale Closure Story.Goldsweig AM, Deng Y, Yao X, Desai NR, Cohen DJ, Aronow HD, Messé SR, Ross JS, Lansky AJ, Savitz ST. Circ Cardiovasc Qual Outcomes. 2024 Jan; 2024 Jan 8. PMID: 38189127.

2023

Hypertension Management in Peripheral Artery Disease: A Mini Review.Kharawala A, Nagraj S, Pargaonkar S, Seo J, Kokkinidis DG, Altin SE. Curr Hypertens Rev. 2023 Dec 11; 2023 Dec 11. PMID: 38083897.
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trial.Lansky AJ, Xu B, Baumbach A, Kelbæk H, van Royen N, Zheng M, Knaapen P, Slagboom T, Johnson TW, Vlachojannis GJ, Arkenbout KE, Holmvang L, Janssens L, Brugaletta S, Naber CK, Schmitz T, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina CM, Buszman PE, Thiele H, Schächinger V, Wijns W. EuroIntervention. 2023 Dec 4; 2023 Dec 4. PMID: 37860860.
How much flow is enough: the use of fractional flow reserve in chronic limb-threatening ischemia in a series of patients with isolated occlusive tibial disease.Ahmed Z, Ochoa-Prieto M, Bhalla A, Strosberg DS, Dardik A, Altin SE. J Vasc Surg Cases Innov Tech. 2023 Dec; 2022 Sep 8. PMID: 38204765.
Intra-Aortic Balloon Pump Exacerbates Left Ventricular Outflow Tract Obstruction in a Patient With Takotsubo and Hypertrophic Cardiomyopathy.Griffin M, Odanovic N, McNamara R, Altin SE, Balan S, Thompson J, Young LH. CASE (Phila). 2023 Dec; 2023 Sep 12. PMID: 38197115.
Persistent Sex Differences After Percutaneous Coronary Intervention: What Are We Missing?Altin SE, Sohal S. Am J Cardiol. 2023 Dec 1; 2023 Oct 19. PMID: 37863706.
Balancing Bleeding and Ischemia After Percutaneous Coronary Intervention: Differential Antiplatelet Outcomes in an East Asian Population.Altin SE, Sohal S. Am J Cardiol. 2023 Dec 1; 2023 Oct 19. PMID: 37863705.
Percutaneous Transluminal Angioplasty for Infrapopliteal Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-analysis of Primary Patency and Binary Restenosis Rates.Snyder DJ, Zilinyi RS, Pruthi S, George S, Tirziu D, Lansky A, Mintz AJ, Sethi SS, Parikh SA. J Endovasc Ther. 2023 Nov 26; 2023 Nov 26. PMID: 38008929.
Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis.Heuts S, Gabrio A, Veenstra L, Maesen B, Kats S, Maessen JG, Walton AS, Nanayakkara S, Lansky AJ, van 't Hof AWJ, Vriesendorp PA. Heart. 2023 Nov 23; 2023 Nov 23. PMID: 37996242.
Predictors of Cerebral Embolic Debris During Transcatheter Aortic Valve Replacement: The SafePass 2 First-in-Human Study.Grubman D, Ahmad Y, Leipsic JA, Blanke P, Pasupati S, Webster M, Nazif TM, Parise H, Lansky AJ. Am J Cardiol. 2023 Nov 15; 2023 Sep 16. PMID: 37722198.
Rationale and design of the INVICTUS Registry: (Multicenter Registry of Invasive and Non-Invasive imaging modalities to compare Coronary Computed Tomography Angiography, Intravascular Ultrasound and Optical Coherence Tomography for the determination of Severity, Volume and Type of coronary atherosclerosiS).Nakanishi R, Okubo R, Sobue Y, Kaneko U, Sato H, Fujimoto S, Nozaki Y, Kajiya T, Miyoshi T, Ichikawa K, Abe M, Kitagawa T, Ikenaga H, Osawa K, Saji M, Iguchi N, Nakazawa G, Takahashi K, Ijich T, Mikamo H, Kurata A, Moroi M, Iijima R, Malkasian S, Crabtree T, Chamie D, Alexandra LJ, Min JK, Earls JP, Matsuo H. J Cardiovasc Comput Tomogr. 2023 Nov-Dec; 2023 Sep 9. PMID: 37679247.